| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/20/2000 | CA2336990A1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 01/20/2000 | CA2336962A1 Methods and compounds for treating depression and other disorders |
| 01/20/2000 | CA2336932A1 Methods and compositions for the treatment of chronic lymphocytic leukemia |
| 01/20/2000 | CA2336848A1 Novel angiogenesis inhibitors |
| 01/20/2000 | CA2336806A1 N-substituted naphthalene carboxamides as neurokinin-receptor antagonists |
| 01/20/2000 | CA2336784A1 Use of tetrahydropyridine or (4-hydroxypiperidine)-butylazoles in the preparation of a medicament for the treatment of pain |
| 01/20/2000 | CA2336748A1 Pharmaceutical preparation |
| 01/20/2000 | CA2336704A1 Composition containing glycerol trinitrate, method for producing said composition and use of the same |
| 01/20/2000 | CA2336703A1 Prophylactic treatments of neovascularisation in macular degeneration |
| 01/20/2000 | CA2335254A1 Bis-indole derivatives and their use as antiinflammatory agents |
| 01/20/2000 | CA2335090A1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2332927A1 Compositions comprising gaba analogs and a decongestant to relieve sinus headache pain |
| 01/20/2000 | CA2332497A1 Presenilin 2 specific ribozyme |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | CA2332311A1 Disintegrin homologs |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972831A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 01/19/2000 | EP0972778A1 Erythromycin derivatives and methods for the preparation thereof |
| 01/19/2000 | EP0972773A1 2-Oxadiazolyl- or 2-thiadiazolyl-phenylcarbamate and -phenylurea derivatives, their preparation and their use as intermediates |
| 01/19/2000 | EP0972769A1 Novel amide derivatives and medicinal compositions thereof |
| 01/19/2000 | EP0972768A1 Process for producing optically active imidazole compounds, intermediates for synthesizing the same, and process for producing the same |
| 01/19/2000 | EP0972762A2 Novel structural analogues of vitamin D |
| 01/19/2000 | EP0972528A2 Radioimmunoconjugate for use in human therapy and its preparation |
| 01/19/2000 | EP0972521A1 Pharmaceutical composition containing stimulators of interferon-gamma |
| 01/19/2000 | EP0972517A2 Use of 1,2,4-benzotriazine oxides for the preparation of a medicament for the treatment of tumours |
| 01/19/2000 | EP0972516A1 Gastro-intestinal adverse effect-free composition comprising an L-carnitine replacement. |
| 01/19/2000 | EP0972515A2 Cyclooxygenase Inhibitor |
| 01/19/2000 | EP0972511A1 Association of a retinoid with a histidine derivative |
| 01/19/2000 | EP0972499A2 Disposable monomer dispenser and vial breaker |
| 01/19/2000 | EP0972454A2 Use of sulfur containing organic compounds as agents for bathochromically shifting the UV/vis-absorption bands of carotenoids |
| 01/19/2000 | EP0972067A1 Method for reversible immobilizing oligo- and/or polysaccharides |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972037A2 $g(b)-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0972019A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer |
| 01/19/2000 | EP0972010A1 Use of the antibacterial active substance triclocarbane in liquid soaps |
| 01/19/2000 | EP0971961A1 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971930A1 Process for preparing single enantiomer narwedine |
| 01/19/2000 | EP0971929A1 2,3-DIHYDROFURO 3,2-$i(b)]PYRIDIN, PREPARATION AND APPLICATION THEREOF IN THERAPY |
| 01/19/2000 | EP0971925A1 Pyrimidopyrimidine compounds |
| 01/19/2000 | EP0971923A2 Synthesis of acyclic nucleoside derivatives |
| 01/19/2000 | EP0971922A1 Tetrahydropyrido compounds |
| 01/19/2000 | EP0971921A1 2-aryl-naphthyridin-4-ones as antitumor agents |
| 01/19/2000 | EP0971920A1 Compounds for inhibition of gastric acid secretion |
| 01/19/2000 | EP0971917A1 Thiazolidinedione and oxazolidinedione derivatives having antidiabetic, hypolipidaemic and antihypertensive properties |
| 01/19/2000 | EP0971915A1 Method for preparing 2-thienylethylamine derivatives |
| 01/19/2000 | EP0971913A1 Process for the production of semi synthetic statins via novel intermediates |
| 01/19/2000 | EP0971910A1 Alpha-methylene gamma lactones as selective cyclooxygenase-2 inhibitors |
| 01/19/2000 | EP0971909A1 Lta 4? hydrolase inhibitors |
| 01/19/2000 | EP0971908A1 Il-8 receptor antagonists |
| 01/19/2000 | EP0971901A1 Phthalazinones |
| 01/19/2000 | EP0971898A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 01/19/2000 | EP0971897A1 Anti-convulsant isoquinolyl-benzamide derivatives |
| 01/19/2000 | EP0971896A1 Quinoline-2-carboxylic acid derivative and its use as excitatory amino acids antagonist |
| 01/19/2000 | EP0971895A1 Hydroxamic acids substituted by heterocycles useful for inhibition of tumor necrosis factor |
| 01/19/2000 | EP0971894A1 Nicotinamide derivatives |
| 01/19/2000 | EP0971892A1 Novel pyridine derivatives and pharmaceutical compositions containing them |
| 01/19/2000 | EP0971891A1 Thrombin inhibitors |
| 01/19/2000 | EP0971888A1 2-alkyl-19-nor-vitamin d compounds |
| 01/19/2000 | EP0971887A1 Metalloproteinase inhibitors |
| 01/19/2000 | EP0971885A1 Process for preparing indane-like compounds |
| 01/19/2000 | EP0971883A1 Retinoid-like compounds |
| 01/19/2000 | EP0971882A1 Nitro-benzamide useful as anti-arrhythmic agent |
| 01/19/2000 | EP0971880A1 Solid compositions suitable for oral administration comprising non hygroscopic salts of l-carnitine and alkanoyl-l-carnitine with 2-aminoethanesulfonic acid |
| 01/19/2000 | EP0971879A1 Solid compositions suitable for oral administration comprising l-carnitine and alkanoyl-l-carnitine magnesium tartrate |
| 01/19/2000 | EP0971873A1 Asiatic acid derivatives and medicines for treating wounds, which contains the same |
| 01/19/2000 | EP0971746A1 Solvent system for enhanced penetration of pharmaceutical compounds |
| 01/19/2000 | EP0971745A2 Gel delivery vehicles for anticellular proliferative agents |
| 01/19/2000 | EP0971744A2 COMBINATION THERAPY EMPLOYING ILEAL BILE ACID TRANSPORT INHIBITING BENZOTHIEPINES AND HMG Co-A REDUCTASE INHIBITORS |
| 01/19/2000 | EP0971743A1 Stabilized medicaments containing cysteinyl derivatives |
| 01/19/2000 | EP0971736A1 Pharmaceutical compositions comprising a polynucleotide and optionally an antigen especially for vaccination |
| 01/19/2000 | EP0971735A1 Methods and compositions for treating inflammatory bowel disease |
| 01/19/2000 | EP0971731A1 Suppression of malignancy utilizing ribonucleotide reductase r1 |
| 01/19/2000 | EP0971719A1 Therapeutic combination of mineral and vitamin in units of liquid preparation for oral administration |
| 01/19/2000 | EP0971717A1 Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles |
| 01/19/2000 | EP0971716A1 Bis-anthracyclines with high activity against doxorubicin resistant tumors |
| 01/19/2000 | EP0971715A1 Mixtures of at least two reverse transcriptase inhibitors and hydroxycarbamide, in particular for inhibiting retroviral spread |
| 01/19/2000 | EP0971714A1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia |
| 01/19/2000 | EP0971713A1 Use of cholinesterase inhibitors to treat disorders of attention |
| 01/19/2000 | EP0971712A1 Compositions for the inhibition of bone resorption |
| 01/19/2000 | EP0971711A1 Anticancer composition comprising a diaminotrifluoromethylpyridine derivative |
| 01/19/2000 | EP0971710A1 Use of chelerythrine and radiation for tumor therapy |
| 01/19/2000 | EP0971707A1 Compositions for the treatment of burns and external ulcers and a process for the preparation thereof |
| 01/19/2000 | EP0971706A2 Vascular remodeling agent |
| 01/19/2000 | EP0971705A1 Hormone replacement therapy drug formulations for topical application to the skin |
| 01/19/2000 | EP0971702A1 Microgranules containing cisplatin |
| 01/19/2000 | EP0971701A1 Method for removing high boiling solvents from drug formulations by vacuum drying |
| 01/19/2000 | EP0971698A1 Aerosolized hydrophobic drug |
| 01/19/2000 | EP0971697A2 Medicament having sclerosing activity |
| 01/19/2000 | EP0971695A1 Isoflavonoids for treatment and prevention of alzheimer dementia and reduced cognitive functions |
| 01/19/2000 | EP0971694A1 Drug preparations for treating sexual dysfunction |
| 01/19/2000 | EP0971693A2 Method of making microencapsulated dna for vaccination and gene therapy |
| 01/19/2000 | EP0971691A2 Combination preparation for orally administered antibiotics |
| 01/19/2000 | EP0971688A1 Opalescent cosmetic compositions and methods for their preparation |
| 01/19/2000 | EP0971686A1 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein |
| 01/19/2000 | EP0971683A1 Compositions comprising santalins, santarubins for artificially coloring the skin |